 - Allogeneic Stem Cell Transplantation: Patients undergo allogeneic bone marrow or peripheral blood stem cell transplantation on days 0 and 1. Patients then receive filgrastim G-CSF subcutaneously daily beginning on day 7 and continuing until blood counts recover. 